MiMedx Group Company Profile (NASDAQ:MDXG)

About MiMedx Group

MiMedx Group logoMiMedx Group, Inc. (MiMedx) is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues and human skin and bone. The Company operates in the Regenerative Biomaterials business segment, which includes the development, processing and marketing of regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues in the wound care, surgical, sports medicine, ophthalmic and dental market categories. Its biomaterial platform technologies are AmnioFix, EpiFix, OrthoFlo, Physio, AlloBurn, and CollaFix. AmnioFix and EpiFix are its tissue technologies processed from human amniotic membrane derived from donated placentas. The Company processes the human amniotic membrane utilizing its PURION Process, to produce an implant. MiMedx is the supplier of amniotic tissue, having supplied over 500,000 allografts.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MDXG
  • CUSIP:
Key Metrics:
  • Previous Close: $8.58
  • 50 Day Moving Average: $8.01
  • 200 Day Moving Average: $7.89
  • 52-Week Range: $6.64 - $10.14
  • Trailing P/E Ratio: 40.66
  • Foreward P/E Ratio: 26.00
  • P/E Growth: 2.83
  • Market Cap: $944.16M
  • Outstanding Shares: 110,042,000
  • Beta: 0.72
Profitability:
  • Net Margins: 10.92%
  • Return on Equity: 22.16%
  • Return on Assets: 15.98%
Debt:
  • Current Ratio: 2.64%
  • Quick Ratio: 2.20%
Additional Links:
Companies Related to MiMedx Group:

Analyst Ratings

Consensus Ratings for MiMedx Group (NASDAQ:MDXG) (?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $11.17 (30.15% upside)

Analysts' Ratings History for MiMedx Group (NASDAQ:MDXG)
Show:
DateFirmActionRatingPrice TargetDetails
8/31/2016Needham & Company LLCReiterated RatingBuy$12.00View Rating Details
6/29/2016Brean CapitalReiterated RatingBuyView Rating Details
4/27/2016First AnalysisDowngradeOverweight -> Equal Weight$14.00 -> $9.00View Rating Details
4/19/2016Lake Street CapitalLower Price TargetBuy$15.00 -> $12.00View Rating Details
1/13/2016Canaccord GenuityReiterated RatingBuy$12.00View Rating Details
10/30/2015Northland SecuritiesUpgradeMarket Perform -> Outperform$10.00View Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for MiMedx Group (NASDAQ:MDXG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/27/2016        
7/26/2016Q216$0.07$0.05$56.49 million$57.00 millionViewListenView Earnings Details
4/26/2016Q116$0.05$0.04$54.05 million$53.40 millionViewListenView Earnings Details
2/23/2016Q415$0.06$0.12$51.84 million$51.80 millionViewListenView Earnings Details
10/29/2015Q315$0.06$0.06$48.61 million$49.00 millionViewListenView Earnings Details
7/30/2015Q215$0.04$0.05$45.03 million$45.68 millionViewListenView Earnings Details
4/27/2015Q1$0.03$0.04ViewListenView Earnings Details
2/26/2015Q414$0.03$0.03$38.15 million$39.60 millionViewListenView Earnings Details
10/30/2014Q314$0.02$0.03$33.50 million$33.50 millionViewListenView Earnings Details
4/25/2014Q114($0.02)($0.01)$19.09 million$19.60 millionViewListenView Earnings Details
2/26/2014Q4($0.01)($0.04)$18.31 million$18.00 millionViewListenView Earnings Details
7/31/2013Q2 2013($0.01)($0.01)$12.94 million$13.52 millionViewListenView Earnings Details
5/1/2013Q1 2013($0.02)($0.02)$11.34 million$11.56 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for MiMedx Group (NASDAQ:MDXG)
Current Year EPS Consensus Estimate: $0.22 EPS
Next Year EPS Consensus Estimate: $0.33 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.03$0.05$0.04
Q2 20163$0.02$0.06$0.05
Q3 20163$0.05$0.08$0.07
Q4 20163$0.08$0.13$0.10
Q1 20172$0.06$0.10$0.08
Q2 20171$0.12$0.12$0.12
Q3 20171$0.13$0.13$0.13
Q4 20171$0.12$0.12$0.12
(Data provided by Zacks Investment Research)

Dividends

Dividend History for MiMedx Group (NASDAQ:MDXG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for MiMedx Group (NASDAQ:MDXG)
Insider Ownership Percentage: 12.30%
Institutional Ownership Percentage: 44.35%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/6/2016William Charles TaylorInsiderSell20,400$7.55$154,020.00View SEC Filing  
8/1/2016William Charles TaylorInsiderSell29,112$7.55$219,795.60View SEC Filing  
6/16/2016William Charles TaylorCOOSell24,333$7.52$182,984.16View SEC Filing  
5/20/2016Parker H PetitCEOBuy20,000$6.99$139,800.00View SEC Filing  
5/17/2016Parker H PetitCEOBuy30,000$6.82$204,600.00View SEC Filing  
5/13/2016Parker H PetitCEOBuy40,000$6.75$270,000.00View SEC Filing  
5/12/2016Parker H PetitCEOBuy50,000$6.74$337,000.00View SEC Filing  
11/13/2015Charles Robert EvansDirectorBuy10,000$7.84$78,400.00View SEC Filing  
11/10/2015Parker H PetitCEOBuy131,925$7.58$999,991.50View SEC Filing  
10/30/2015Alexandra O. HadenGeneral CounselBuy4,150$7.92$32,868.00View SEC Filing  
5/28/2015Larry W PapasanDirectorSell5,958$10.09$60,116.22View SEC Filing  
5/18/2015William Charles TaylorCOOSell150,000$10.01$1,501,500.00View SEC Filing  
10/31/2014William Charles TaylorCOOSell150,000$10.01$1,501,500.00View SEC Filing  
7/1/2014William Charles TaylorCOOSell150,000$7.50$1,125,000.00View SEC Filing  
1/17/2014Parker PetitCEOSell150,000$8.28$1,242,000.00View SEC Filing  
8/28/2013William Charles TaylorCOOSell9,800$6.15$60,270.00View SEC Filing  
8/7/2013William Charles TaylorCOOSell183,765$6.21$1,141,180.65View SEC Filing  
5/16/2013Steve GorlinDirectorSell30,000$6.46$193,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for MiMedx Group (NASDAQ:MDXG)
DateHeadline
News IconLatest Analyst Ratings For MiMedx Group, Inc (MDXG) - The De ... - The De Soto Edge (NASDAQ:MDXG)
www.desotoedge.com - September 30 at 11:18 AM
News IconConsensus Take: MiMedx Group, Inc (NASDAQ:MDXG) Earnings & Ratings Watch - Frisco Fastball (NASDAQ:MDXG)
friscofastball.com - September 30 at 11:18 AM
finance.yahoo.com logoMiMedx at the 5th Congress of World Union Wound Healing Societies (NASDAQ:MDXG)
finance.yahoo.com - September 29 at 6:02 PM
News IconThe Statistics Don't Lie: MiMedx Group, Inc. (NASDAQ:MDXG) Earnings Preview - The Voice Registrar (NASDAQ:MDXG)
voiceregistrar.com - September 27 at 5:59 PM
realistinvestor.com logoMiMedx Group, Inc (NASDAQ:MDXG) Mean Price Target Is $11.6 - RealistInvestor.com (NASDAQ:MDXG)
www.realistinvestor.com - September 24 at 10:32 AM
News IconAnalysts Valuations For Two Stocks: Microsemi Corporation (NASDAQ:MSCC), MiMedx Group Inc (NASDAQ:MDXG) - The Voice Registrar (NASDAQ:MDXG)
voiceregistrar.com - September 17 at 10:36 AM
News IconTechnical Roundup on Healthcare Stocks -- ResMed, MiMedx, Varian Medical Systems, and Accuray (NASDAQ:MDXG)
www.traderplanet.com - September 16 at 9:43 AM
finance.yahoo.com logoMiMedx Urges FDA To Reconsider Draft Guidances During Hearing (NASDAQ:MDXG)
finance.yahoo.com - September 15 at 9:30 AM
finance.yahoo.com logoScientific Study Confirms How MiMedx dHACM Allografts Effectively Promote Wound Repair (NASDAQ:MDXG)
finance.yahoo.com - September 12 at 10:46 AM
capitalcube.com logoETF’s with exposure to MiMedx Group, Inc. : September 8, 2016 (NASDAQ:MDXG)
www.capitalcube.com - September 8 at 5:54 PM
istreetwire.com logoStocks in the Spotlight: Belden Inc. (BDC), MiMedx Group, Inc. (MDXG), Quest Diagnostics Inc. (DGX) - iStreetWire (NASDAQ:MDXG)
istreetwire.com - September 8 at 9:57 AM
News IconPlacing MiMedx Group, Inc (NASDAQ:MDXG) Shares Under the Microscope - Post News (NASDAQ:MDXG)
www.kentuckypostnews.com - September 8 at 9:57 AM
News IconHot Line At Active Movers- BioMarin Pharmaceutical (NASDAQ:BMRN), MiMedx Group (NASDAQ:MDXG), B2Gold ... - Seneca Globe (NASDAQ:MDXG)
www.senecaglobe.com - September 7 at 6:15 PM
News IconStocks Roundup: Williams Partners LP (NYSE:WPZ), MiMedx Group Inc (NASDAQ:MDXG), ChemoCentryx Inc ... - NYSE Journal (press release) (NASDAQ:MDXG)
stockznews.com - September 7 at 6:15 PM
biz.yahoo.com logoMiMedx Group Inc Conference Call to Provide Update On Clinical Trials scheduled for 10:30 am ET today (NASDAQ:MDXG)
biz.yahoo.com - September 7 at 6:15 PM
capitalcube.com logoMiMedx Group, Inc. breached its 50 day moving average in a Bullish Manner : MDXG-US : September 7, 2016 (NASDAQ:MDXG)
www.capitalcube.com - September 7 at 9:39 AM
benzinga.com logoInvestors Cheer MiMedx Reaffirmation Of Full-Year Forecast (NASDAQ:MDXG)
www.benzinga.com - September 6 at 6:10 PM
finance.yahoo.com logoMiMedx Reaffirms Q3 and Full Year 2016 Guidance (NASDAQ:MDXG)
finance.yahoo.com - September 6 at 10:49 AM
News IconMiMedx Provides Update On Key Clinical Trials (NASDAQ:MDXG)
www.orthospinenews.com - September 4 at 10:18 AM
investornewswire.com logoMiMedx Group, Inc (NASDAQ:MDXG) Analyst Rating Update - Investor Newswire (NASDAQ:MDXG)
www.investornewswire.com - September 2 at 3:25 PM
News IconMiMedx Announces Nationwide Launch of AmnioFill™ (NASDAQ:MDXG)
www.orthospinenews.com - September 2 at 10:54 AM
streetinsider.com logoMiMedx Group (MDXG) Launches AmnioFill Nationwide (NASDAQ:MDXG)
www.streetinsider.com - September 2 at 10:54 AM
News IconWill MiMedx Group, Inc. (MDXG) miss earning estimates again? - The Independent Republic (NASDAQ:MDXG)
theindependentrepublic.com - September 1 at 5:58 PM
streetinsider.com logoMiMedx Group (MDXG) Launches AmnioFill Nationwide - StreetInsider.com (NASDAQ:MDXG)
www.streetinsider.com - September 1 at 5:58 PM
streetinsider.com logoMiMedx Group (MDXG) Updates on Program Progress; Says BLA/PMA Compliant Chronic Wound Clinical Trials Near ... - StreetInsider.com (NASDAQ:MDXG)
www.streetinsider.com - August 31 at 10:58 AM
finance.yahoo.com logoMiMedx To Attend The Morgan Stanley Global Healthcare Conference (NASDAQ:MDXG)
finance.yahoo.com - August 30 at 6:06 PM
News IconShares Holding Above Moving Averages: MiMedx Group, Inc. (NASDAQ:MDXG) - Post News (NASDAQ:MDXG)
www.kentuckypostnews.com - August 30 at 9:29 AM
streetinsider.com logoMiMedx Group (MDXG) Announces Issuance of Six New U.S. Patents; Offers Portfolio Update - StreetInsider.com (NASDAQ:MDXG)
www.streetinsider.com - August 30 at 9:29 AM
finance.yahoo.com logoMiMedx Awarded Six New U.S. Patents with Five Awarded for its Amniotic Membrane Allografts and One Awarded for its CollaFix™ Technology (NASDAQ:MDXG)
finance.yahoo.com - August 29 at 6:02 PM
streetinsider.com logoMiMedx Group (MDXG) Announces Issuance of Six New U.S. Patents; Offers Portfolio Update (NASDAQ:MDXG)
www.streetinsider.com - August 29 at 6:02 PM
News IconCrowd & Street Analysis on MiMedx Group, Inc (NASDAQ:MDXG) - Post News (NASDAQ:MDXG)
www.kentuckypostnews.com - August 25 at 6:04 PM
finance.yahoo.com logoMiMedx Amniotic Allografts Are Terminally Sterilized To Enhance Safety Related To Microbiological And Viral Transmission (NASDAQ:MDXG)
finance.yahoo.com - August 22 at 6:06 PM
News IconCrowd Perspectives & Broker Views on MiMedx Group, Inc (NASDAQ:MDXG)? - Post News (NASDAQ:MDXG)
www.kentuckypostnews.com - August 20 at 10:14 AM
capitalcube.com logoETF’s with exposure to MiMedx Group, Inc. : August 18, 2016 (NASDAQ:MDXG)
www.capitalcube.com - August 19 at 9:10 AM
News IconConsensus Take: MiMedx Group, Inc (NASDAQ:MDXG) Earnings ... - Post News (NASDAQ:MDXG)
www.kentuckypostnews.com - August 18 at 6:14 PM
capitalcube.com logoMiMedx Group, Inc. :MDXG-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:MDXG)
www.capitalcube.com - August 12 at 6:13 PM
streetinsider.com logoMiMedx Group (MDXG) Says '687 Patent Ruled Invalid - StreetInsider.com (NASDAQ:MDXG)
www.streetinsider.com - August 12 at 9:22 AM
streetinsider.com logoMiMedx Group (MDXG) Says '687 Patent Ruled Invalid (NASDAQ:MDXG)
www.streetinsider.com - August 11 at 6:29 PM
finance.yahoo.com logoMiMedx announces ruling from PTAB on its embossment patent (NASDAQ:MDXG)
finance.yahoo.com - August 11 at 6:29 PM
finance.yahoo.com logo2:53 pm MiMedx Group announces ruling from the PTAB with regard to MiMedx's United States Patent No. 8,597,687 related to the embossment of tissues (NASDAQ:MDXG)
finance.yahoo.com - August 11 at 6:29 PM
finance.yahoo.com logoMIMEDX GROUP, INC. Financials (NASDAQ:MDXG)
finance.yahoo.com - August 10 at 6:33 PM
realistinvestor.com logoMiMedx Group, Inc (NASDAQ:MDXG) Mean Price Target At $11.5 - RealistInvestor.com (NASDAQ:MDXG)
www.realistinvestor.com - August 7 at 5:50 PM
finance.yahoo.com logoMiMedx to Present at the 36th Annual Canaccord|Genuity Growth Conference (NASDAQ:MDXG)
finance.yahoo.com - August 3 at 9:26 AM
biz.yahoo.com logoMIMEDX GROUP, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:MDXG)
biz.yahoo.com - August 2 at 6:26 PM
realistinvestor.com logoCan MiMedx Group, Inc (NASDAQ:MDXG) Hit $13? - RealistInvestor.com (NASDAQ:MDXG)
www.realistinvestor.com - July 30 at 8:58 AM
News IconTraders Recap - JetBlue Airways Corporation, (NASDAQ:JBLU), MiMedx Group, (NASDAQ:MDXG) - Hot Stocks Point (NASDAQ:MDXG)
www.hotstockspoint.com - July 27 at 6:26 PM
fortune.com logoMiMedx Group, Inc. (NASDAQ:MDXG) at $7.53: How much higher it can go - Review Fortune (NASDAQ:MDXG)
reviewfortune.com - July 27 at 6:26 PM
finance.yahoo.com logoEdited Transcript of MDXG earnings conference call or presentation 26-Jul-16 2:30pm GMT (NASDAQ:MDXG)
finance.yahoo.com - July 27 at 11:40 AM
cnbc.com logoMiMedx meets 2Q profit forecasts (NASDAQ:MDXG)
www.cnbc.com - July 26 at 6:26 PM
tradecalls.org logoMiMedx Group Inc (MDXG) Shares are Down -2.63% - Trade Calls (NASDAQ:MDXG)
www.tradecalls.org - July 25 at 6:16 PM

Social

MiMedx Group (NASDAQ:MDXG) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff